SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-433496
Filing Date
2014-12-04
Accepted
2014-12-04 16:21:00
Documents
2
Period of Report
2014-12-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d833538d8k.htm 8-K 14315
2 EX-99.1 d833538dex991.htm EX-99.1 7137
  Complete submission text file 0001193125-14-433496.txt   22534
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36070 | Film No.: 141266679
SIC: 2834 Pharmaceutical Preparations